Media headlines about Innospec (NASDAQ:IOSP) have trended somewhat positive recently, according to Accern Sentiment. The research firm identifies positive and negative press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Innospec earned a daily sentiment score of 0.17 on Accern’s scale. Accern also assigned headlines about the specialty chemicals company an impact score of 46.3837144891397 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
These are some of the headlines that may have impacted Accern Sentiment Analysis’s analysis:
- ETFs with exposure to Innospec, Inc. : November 2, 2017 (finance.yahoo.com)
- Innospec Inc. (IOSP) Given $69.00 Average Target Price by Brokerages (americanbankingnews.com)
- Reviewing Innospec (IOSP) & Its Rivals (americanbankingnews.com)
- Innospec Inc. (IOSP) Set to Announce Earnings on Tuesday (americanbankingnews.com)
Shares of Innospec (IOSP) traded down $0.30 on Friday, reaching $63.00. 83,602 shares of the company’s stock were exchanged, compared to its average volume of 85,958. The company has a current ratio of 2.28, a quick ratio of 1.32 and a debt-to-equity ratio of 0.34. The firm has a market capitalization of $1,520.63, a PE ratio of 15.63 and a beta of 1.16. Innospec has a one year low of $54.10 and a one year high of $74.75.
Innospec (NASDAQ:IOSP) last announced its earnings results on Tuesday, August 8th. The specialty chemicals company reported $1.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.08. The company had revenue of $326.30 million during the quarter. Innospec had a net margin of 7.22% and a return on equity of 14.77%. research analysts predict that Innospec will post 4.15 earnings per share for the current fiscal year.
IOSP has been the subject of several recent analyst reports. BidaskClub cut shares of Innospec from a “sell” rating to a “strong sell” rating in a research note on Thursday, July 27th. Zacks Investment Research cut shares of Innospec from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, July 12th. Monness Crespi & Hardt upgraded shares of Innospec from a “neutral” rating to a “buy” rating and set a $65.00 target price for the company in a research report on Tuesday, August 22nd. Finally, ValuEngine cut shares of Innospec from a “buy” rating to a “hold” rating in a research report on Monday, August 7th.
Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.
What are top analysts saying about Innospec Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Innospec Inc. and related companies.